临沧哪家医院宫颈糜烂哪家好(临沧阴道口出血怎么回事) (今日更新中)

WASHINGTON, Aug. 2 (Xinhua) -- A new study has identified the recent emergence of a multidrug-resistant strain of Salmonella that has a high level resistance to ciprofloxacin, a common treatment for severe Salmonella infections. The study was published on-line Tuesday in The Journal of Infectious Diseases.Francois-Xavier Weill at the Pasteur Institute in France and colleagues studied information from national surveillance systems in France, England and Wales, Denmark, and the United States. The data showed that a multidrug-resistant strain of Salmonella, known as S. Kentucky, infected 489 patients in France, England and Wales, and Denmark between 2000 and 2008. In addition, researchers reported that the first infections were acquired mainly in Egypt between 2002 and 2005, while since 2006 the infections have also been acquired in various parts of Africa and the Middle East. The absence of reported international travel in approximately 10 percent of the patients suggests that infections may have also occurred in Europe through consumption of contaminated imported foods or through secondary contaminations.In this study, multidrug-resistant S. Kentucky was isolated from chickens and turkeys from Ethiopia, Morocco, and Nigeria, suggesting that poultry is an important agent for infection. The common use of fluoroquinolones in chicken and turkey production in Nigeria and Morocco may have contributed to this rapid spread, according to the researchers.This study highlights the importance of public health surveillance in a global food system. The investigators reported that they will continue to monitor this multidrug-resistant strain as well as help strengthen the capacities of national and regional laboratories in the surveillance of Salmonella and other major foodborne pathogens through the World Health Organization Global Foodborne Infections Network.Salmonella infection represents a major public health problem worldwide. An estimated 1.7 million such infections occur in North America each year. More than 1.6 million cases were reported between 1999 and 2008 in 27 European countries. Although most Salmonella infections produce only mild gastroenteritis, elderly and immunocompromised patients are especially at risk for life- threatening infections. These cases are typically treated with antimicrobials called fluoroquinolones, such as ciprofloxacin.

CANBERRA, Sept. 9 (Xinhua) -- Australia on Friday launched the first national study to find out whether low to moderate levels of alcohol drank by pregnant women are harmful or not to an unborn child, hoping to provide a clear indication about the safe amount of alcohol for pregnant women.The Murdoch Children's Research Institute in Melbourne, which commissioned the study, is recruiting 2000 pregnant women who will be quizzed throughout their pregnancy about their drinking habits, general health and diets.Their babies will then undergo medical checks, when they turn one and again at two to see if their brains, development and behavior was affected by alcohol consumed by their mums.According to lead researcher associate professor, Jane Halliday, while there was solid evidence about the dangers of heavy drinking for an unborn baby, it was not known if there was a safe amount of alcohol pregnant women could drink.She said the study hoped to shed light on the best approach to alcohol use during pregnancy."The problem is that for about half of women that get pregnant it is unplanned, and a lot of women are drinking around the time they get pregnant and may drink for the first month or so and that creates a lot of anxiety," Assoc Prof Halliday said in a statement."From the few international and Australian studies there's conflicting evidence as to whether there's an adverse effect."We firmly believe that no drinking is the safest option, but our main aim is to provide an evidence base to the policy and answer questions about individual risks."The study came after research by the University of Newcastle published in 2010 revealed 80 percent of Australian women drank during pregnancy.

BEIJING, Aug. 10 (Xinhuanet) -- A new technology can tell pregnant women whether they're having a boy or girl as early as seven weeks into a pregnancy -- months earlier than usual, according to media reports Wednesday.The technology works by detecting "cell-free fetal DNA," or DNA from the fetus, which floats freely in a pregnant woman's blood, said author Diana Bianchi of the Tufts University School of Medicine in Boston. Her analysis of 57 studies from peer-reviewed medical journals showed that these blood tests, common in Europe but not in the U.S. can reveal a fetus' sex only a week or two after a pregnant woman misses her period. Women usually learn the fetus' sex through an ultrasound at 18 to 20 weeks.The technology will help families worried by having a child with rare genetic disorders that typically affect only boys, such as hemophilia or a type of muscular dystrophy, said Joseph Biggio, director of the Trimester Genetics Screening Clinic at the University of Alabama-Birmingham.If they're having a girl, however, they can stop worrying, he added, and avoid further invasive tests, which can provide a definitive answer about genetic disorders, but also increase the risk of miscarriage. Women who learn they're carrying boys would still need a definitive test, such as an amniocentesis, to find out if their fetus is affected.

BEIJING, Sept. 21 (Xinhuanet) -- China will launch an unmanned module next week, paving the way for a planned space station, a spokesman for the space program said on Tuesday.Tiangong-1, or "Heavenly Palace 1", will blast off from Jiuquan Satellite Launch Center in Gansu province between Sept 27 and 30, the spokesman said.The 8.5-ton module, and the Long March II-F rocket that will carry it skyward, were positioned onto the launch pad on Tuesday, signaling that the project has entered the final preparation stage."Scientists will conduct final tests in the next few days before injecting propellants for the launch," Cui Jijun, director of the Jiuquan Satellite Launch Center, said.The program spokesman said that Tiangong-1 will serve as "a target spacecraft" for rendezvous and docking experiments.It will also work as "a platform to test long-term unmanned and short-term manned operations", he said.Technical and medical experiments will provide crucial data ahead of the building of the space station (scheduled for 2020).Three rendezvous and docking experiments will be conducted.An unmanned Shenzhou-VIII craft will be launched later this year to dock with Tiangong-1. In 2012, Shenzhou IX and Shenzhou X will blast off to complete at least one manned docking.Jiao Weixin, a space scientist at Peking University, said that rendezvous and docking - vital maneuvers for manned programs - are hard to master."Rendezvous and docking are difficult because it is like asking two racing cars to keep a distance of 1 meter between them," he said.The mission requires two craft, traveling at speeds of 28,000 km/h, to enter the same orbit and connect with precision, he said.The China Manned Space Engineering Office rescheduled the launch of Tiangong-1 after the failed launch of an experimental orbiter last month.The spokesman said that the carrier rocket to blast off with Tiangong-1 atop has been modified.Only the United States and Russia have mastered rendezvous and docking technology, said Pang Zhihao, deputy editor-in-chief of the magazine Space International.Spacecraft developed by Europe and Japan have utilized US and Russian technology to dock with the International Space Station, he added.

WASHINGTON, June 6 (Xinhua) -- Women who have higher levels of the appetite-controlling hormone leptin have fewer symptoms of depression, and this apparent inverse relationship is not related to body mass index (BMI), a new study finds. The results were presented Monday at The Endocrine Society's 93rd Annual Meeting in Boston, the United States."Animal data suggest that leptin may reduce anxiety and improve depression. Our study in women suggests that leptin may indeed have antidepressant qualities," said the study's lead author, Elizabeth Lawson, of Massachusetts General Hospital and Harvard Medical School in Boston.Leptin, the product of fat cells, signals satiety, or fullness. It is low in thin women and high in obese women, according to Lawson. She also said there is an increased prevalence of anxiety and depression in certain conditions in which leptin levels are typically low. These include the eating disorder anorexia nervosa, in which there is abnormally low weight and body fat, and functional hypothalamic amenorrhea, in which women have stopped menstruating despite having normal weight."It is unknown whether low leptin levels contribute to the development of mood disorders in these women," Lawson said.She and her co-workers studied the relationship between leptin levels and symptoms of anxiety and depression in 64 women. Fifteen of the women had anorexia nervosa, 12 were normal weight with hypothalamic amenorrhea, 20 were normal weight and in good health, and 17 were overweight or obese but still healthy.All subjects were asked questions to assess symptoms of depression and anxiety, with high scores indicating more symptoms. Besides measuring leptin levels in the blood, the researchers assessed the women's BMI, a measure of weight for height.The relationship between leptin and depression symptoms was independent of BMI. This finding indicates that leptin may mediate symptoms of depression and that this effect is not a function of low weight, Lawson said."Further research administering leptin to humans will be important in understanding whether this hormone has a potential role in the treatment of depression," she said.

来源：资阳报